{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:56:41Z","timestamp":1784120201238,"version":"3.55.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060359 and 82360382"],"award-info":[{"award-number":["82060359 and 82360382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Province Social Development Project","award":["Qiankehe [2021] General 088"],"award-info":[{"award-number":["Qiankehe [2021] General 088"]}]},{"name":"Key Project of Guizhou Natural Science Foundation","award":["Qiankehe Fundamentals ZK [2022] Key 049"],"award-info":[{"award-number":["Qiankehe Fundamentals ZK [2022] Key 049"]}]},{"name":"Guizhou Province Excellent Youth Science and Technology Talent Project","award":["Qiankehe Platform Talent [2021] No. 5648"],"award-info":[{"award-number":["Qiankehe Platform Talent [2021] No. 5648"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02748-7","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:35:43Z","timestamp":1760614543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leptin\u2019s potential mechanisms in ICU-acquired weakness"],"prefix":"10.1186","volume":"24","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2748_CR1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17376.1","author":"S Piva","year":"2019","unstructured":"Piva S, Fagoni N, Latronico N. Intensive care unit-acquired weakness: unanswered questions and targets for future research. F1000Res. 2019. https:\/\/doi.org\/10.12688\/f1000research.17376.1.","journal-title":"F1000Res"},{"issue":"1","key":"2748_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0993-7","volume":"19","author":"G Hermans","year":"2015","unstructured":"Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19(1):274.","journal-title":"Crit Care"},{"issue":"1","key":"2748_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jointm.2023.07.002","volume":"4","author":"J Chen","year":"2024","unstructured":"Chen J, Huang M. Intensive care unit-acquired weakness: recent insights. J Intensive Med. 2024;4(1):73\u201380.","journal-title":"J Intensive Med"},{"issue":"16","key":"2748_CR4","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1113\/JP283034","volume":"600","author":"KH Collins","year":"2022","unstructured":"Collins KH, Gui C, Ely EV, Lenz KL, Harris CA, Guilak F, et al. Leptin mediates the regulation of muscle mass and strength by adipose tissue. J Physiol. 2022;600(16):3795\u2013817.","journal-title":"J Physiol"},{"issue":"2","key":"2748_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","volume":"13","author":"V Abella","year":"2017","unstructured":"Abella V, Scotece M, Conde J, Pino J, Gonzalez-Gay MA, G\u00f3mez-Reino JJ, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100\u20139.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"2748_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","volume":"77","author":"N Perakakis","year":"2021","unstructured":"Perakakis N, Farr OM, Mantzoros CS. Leptin in leanness and obesity: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(6):745\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2748_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12879-025-10829-2","volume":"25","author":"YH Tsai","year":"2025","unstructured":"Tsai YH, Hung KY, Fang WF. Leptin and Iinterlukin-6 relationship and influence of mortality in sepsis. BMC Infect Dis. 2025;25(1):460.","journal-title":"BMC Infect Dis"},{"key":"2748_CR8","doi-asserted-by":"crossref","unstructured":"Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F. Relevance of serum leptin and leptin-receptor concentrations in critically ill patients.\u00a0Mediators Inflamm. 2010;2010:473540.","DOI":"10.1155\/2010\/473540"},{"key":"2748_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clnesp.2025.03.176","volume":"68","author":"A Kolahi","year":"2025","unstructured":"Kolahi A, Gholizadeh M, Shab-Bidar S. Adipokines in critically ill patients: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN. 2025;68:216\u201327.","journal-title":"Clin Nutr ESPEN"},{"issue":"9","key":"2748_CR10","first-page":"3062","volume":"83","author":"G Van den Berghe","year":"1998","unstructured":"Van den Berghe G, Wouters P, Carlsson L, Baxter RC, Bouillon R, Bowers CY. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. J Clin Endocrinol Metab. 1998;83(9):3062\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"2748_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.559789","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Xu C, Ma X, Zhang X, Xie P. Intensive care unit-acquired weakness: a review of recent progress with a look toward the future. Front Med. 2020;7:559789.","journal-title":"Front Med"},{"issue":"11","key":"2748_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/thoraxjnl-2016-208312","volume":"74","author":"J Batt","year":"2019","unstructured":"Batt J, Herridge MS, Dos Santos CC. From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective. Thorax. 2019;74(11):1091\u20138.","journal-title":"Thorax"},{"issue":"2","key":"2748_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00134-005-0029-x","volume":"32","author":"M Eikermann","year":"2006","unstructured":"Eikermann M, Koch G, Gerwig M, Ochterbeck C, Beiderlinden M, Koeppen S, et al. Muscle force and fatigue in patients with sepsis and multiorgan failure. Intensive Care Med. 2006;32(2):251\u20139.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2748_CR14","volume":"42","author":"P Bellaver","year":"2023","unstructured":"Bellaver P, Schaeffer AF, Leitao CB, Rech TH, Nedel WL. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): a systematic review with meta-analysis and trial sequential analysis. Anaesth Crit Care Pain Med. 2023;42(3):101202.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"2","key":"2748_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13539-010-0010-6","volume":"1","author":"JC Schefold","year":"2010","unstructured":"Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010;1(2):147\u201357.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2748_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1183\/09031936.00090011","volume":"39","author":"S Bloch","year":"2012","unstructured":"Bloch S, Polkey MI, Griffiths M, Kemp P. Molecular mechanisms of intensive care unit-acquired weakness. Eur Respir J. 2012;39(4):1000\u201311.","journal-title":"Eur Respir J"},{"issue":"15","key":"2748_CR17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2013.278481","volume":"310","author":"ZA Puthucheary","year":"2013","unstructured":"Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591\u2013600.","journal-title":"JAMA"},{"issue":"1","key":"2748_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04253-0","volume":"27","author":"B Fazzini","year":"2023","unstructured":"Fazzini B, M\u00e4rkl T, Costas C, Blobner M, Schaller SJ, Prowle J, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2.","journal-title":"Crit Care"},{"issue":"6","key":"2748_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/jcsm.12620","volume":"11","author":"JC Schefold","year":"2020","unstructured":"Schefold JC, Wollersheim T, Grunow JJ, Luedi MM, Z\u2019Graggen WJ, Weber-Carstens S. Muscular weakness and muscle wasting in the critically ill. J Cachexia Sarcopenia Muscle. 2020;11(6):1399\u2013412.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"2748_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00134-017-4757-5","volume":"43","author":"N Latronico","year":"2017","unstructured":"Latronico N, Herridge M, Hopkins RO, Angus D, Hart N, Hermans G, et al. The ICM research agenda on intensive care unit-acquired weakness. Intensive Care Med. 2017;43(9):1270\u201381.","journal-title":"Intensive Care Med"},{"issue":"4","key":"2748_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00134-020-05944-4","volume":"46","author":"I Vanhorebeek","year":"2020","unstructured":"Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637\u201353.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2748_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0780-5","volume":"19","author":"SM Parry","year":"2015","unstructured":"Parry SM, Berney S, Granger CL, Dunlop DL, Murphy L, El-Ansary D, et al. A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study. Crit Care. 2015;19(1):52.","journal-title":"Crit Care"},{"issue":"3","key":"2748_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00028.2014","volume":"95","author":"O Friedrich","year":"2015","unstructured":"Friedrich O, Reid MB, Van den Berghe G, Vanhorebeek I, Hermans G, Rich MM, et al. The sick and the weak: neuropathies\/myopathies in the critically ill. Physiol Rev. 2015;95(3):1025\u2013109.","journal-title":"Physiol Rev"},{"issue":"10","key":"2748_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","volume":"10","author":"N Latronico","year":"2011","unstructured":"Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931\u201341.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2748_CR25","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1152\/japplphysiol.00019.2021","volume":"130","author":"K Cheung","year":"2021","unstructured":"Cheung K, Rathbone A, Melanson M, Trier J, Ritsma BR, Allen MD. Pathophysiology and management of critical illness polyneuropathy and myopathy. J Appl Physiol. 2021;130(5):1479\u201389.","journal-title":"J Appl Physiol"},{"issue":"3","key":"2748_CR26","first-page":"Cd010942","volume":"2015","author":"J Mehrholz","year":"2015","unstructured":"Mehrholz J, Pohl M, Kugler J, Burridge J, M\u00fcckel S, Elsner B. Physical rehabilitation for critical illness myopathy and neuropathy. Cochrane Database Syst Rev. 2015;2015(3):Cd010942.","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"2748_CR27","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMra1209390","volume":"370","author":"JP Kress","year":"2014","unstructured":"Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626\u201335.","journal-title":"N Engl J Med"},{"issue":"6","key":"2748_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/CCM.0000000000002447","volume":"45","author":"RD Stevens","year":"2017","unstructured":"Stevens RD, Zink EK. Inflammatory signatures in ICU-Acquired weakness. Crit Care Med. 2017;45(6):1098\u2013100.","journal-title":"Crit Care Med"},{"issue":"6","key":"2748_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/CCM.0000000000001643","volume":"44","author":"CL Hodgson","year":"2016","unstructured":"Hodgson CL, Bailey M, Bellomo R, Berney S, Buhr H, Denehy L, et al. A binational multicenter pilot feasibility randomized controlled trial of early goal-directed mobilization in the ICU. Crit Care Med. 2016;44(6):1145\u201352.","journal-title":"Crit Care Med"},{"issue":"10052","key":"2748_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)31637-3","volume":"388","author":"SJ Schaller","year":"2016","unstructured":"Schaller SJ, Anstey M, Blobner M, Edrich T, Grabitz SD, Gradwohl-Matis I, et al. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet. 2016;388(10052):1377\u201388.","journal-title":"Lancet"},{"issue":"2","key":"2748_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00134-016-4612-0","volume":"43","author":"CJ Tipping","year":"2017","unstructured":"Tipping CJ, Harrold M, Holland A, Romero L, Nisbet T, Hodgson CL. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med. 2017;43(2):171\u201383.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2748_CR32","first-page":"Cd006832","volume":"2014","author":"G Hermans","year":"2014","unstructured":"Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2014;2014(1):Cd006832.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2748_CR33","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/CCM.0000000000005941","volume":"51","author":"N Nakanishi","year":"2023","unstructured":"Nakanishi N, Yoshihiro S, Kawamura Y, Aikawa G, Shida H, Shimizu M, et al. Effect of neuromuscular electrical stimulation in patients with critical illness: an updated systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2023;51(10):1386\u201396.","journal-title":"Crit Care Med"},{"key":"2748_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.biochi.2023.04.011","volume":"212","author":"X Fan","year":"2023","unstructured":"Fan X, Yuan W, Huang W, Lin Z. Recent progress in leptin signaling from a structural perspective and its implications for diseases. Biochimie. 2023;212:60\u201375.","journal-title":"Biochimie"},{"issue":"1","key":"2748_CR35","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41467-023-37169-6","volume":"14","author":"RA Saxton","year":"2023","unstructured":"Saxton RA, Caveney NA, Moya-Garzon MD, Householder KD, Rodriguez GE, Burdsall KA, et al. Structural insights into the mechanism of leptin receptor activation. Nat Commun. 2023;14(1):1797.","journal-title":"Nat Commun"},{"issue":"1","key":"2748_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2014.09.010","volume":"64","author":"H M\u00fcnzberg","year":"2015","unstructured":"M\u00fcnzberg H, Morrison CD. Structure, production and signaling of leptin. Metab Clin Exp. 2015;64(1):13\u201323.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"2748_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/j.2040-4603.2018.tb00002.x","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chua S. Jr. Leptin function and regulation. Compr Physiol. 2017;8(1):351\u201369.","journal-title":"Compr Physiol"},{"key":"2748_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2018.10.002","volume":"44","author":"T Wang","year":"2018","unstructured":"Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"2748_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s42255-019-0095-y","volume":"1","author":"JM Friedman","year":"2019","unstructured":"Friedman JM. Leptin and the endocrine control of energy balance. Nat Metab. 2019;1(8):754\u201364.","journal-title":"Nat Metab"},{"issue":"1","key":"2748_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/1028415X.2022.2161135","volume":"27","author":"JAL Tucker","year":"2024","unstructured":"Tucker JAL, Bornath DPD, McCarthy SF, Hazell TJ. Leptin and energy balance: exploring leptin\u2019s role in the regulation of energy intake and energy expenditure. Nutr Neurosci. 2024;27(1):87\u201395.","journal-title":"Nutr Neurosci"},{"issue":"11\u201312","key":"2748_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14(11\u201312):741\u201351.","journal-title":"Mol Med"},{"issue":"3","key":"2748_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/humupd\/dmv057","volume":"22","author":"A Catteau","year":"2016","unstructured":"Catteau A, Caillon H, Barri\u00e8re P, Denis MG, Masson D, Fr\u00e9our T. Leptin and its potential interest in assisted reproduction cycles. Hum Reprod Update. 2016;22(3):320\u201341.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2748_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s12031-013-0093-6","volume":"51","author":"Y Wang","year":"2013","unstructured":"Wang Y, He J, Kastin AJ, Hsuchou H, Pan W. Hypersomnolence and reduced activity in pan-leptin receptor knockout mice. J Mol Neurosci. 2013;51(3):1038\u201345.","journal-title":"J Mol Neurosci"},{"key":"2748_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156026","volume":"161","author":"H M\u00fcnzberg","year":"2024","unstructured":"M\u00fcnzberg H, Heymsfield SB, Berthoud HR, Morrison CD. History and future of leptin: discovery, regulation and signaling. Metabolism. 2024;161:156026.","journal-title":"Metabolism"},{"issue":"1\u20132","key":"2748_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/A:1012978525492","volume":"4","author":"M Sone","year":"2001","unstructured":"Sone M, Osamura RY. Leptin and the pituitary. Pituitary. 2001;4(1\u20132):15\u201323.","journal-title":"Pituitary"},{"issue":"5","key":"2748_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10528-016-9751-z","volume":"54","author":"M Wasim","year":"2016","unstructured":"Wasim M, Awan FR, Najam SS, Khan AR, Khan HN. Role of leptin deficiency, inefficiency, and leptin receptors in obesity. Biochem Genet. 2016;54(5):565\u201372.","journal-title":"Biochem Genet"},{"issue":"2","key":"2748_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.celrep.2017.03.043","volume":"19","author":"K Timper","year":"2017","unstructured":"Timper K, Denson JL, Steculorum SM, Heilinger C, Engstr\u00f6m-Ruud L, Wunderlich CM, et al. IL-6 improves energy and glucose homeostasis in obesity via enhanced central IL-6 trans-signaling. Cell Rep. 2017;19(2):267\u201380.","journal-title":"Cell Rep"},{"issue":"1","key":"2748_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1210\/js.2018-00123","volume":"3","author":"A Nunziata","year":"2019","unstructured":"Nunziata A, Funcke JB, Borck G, von Schnurbein J, Brandt S, Lennerz B, et al. Functional and phenotypic characteristics of human leptin receptor mutations. J Endocr Soc. 2019;3(1):27\u201341.","journal-title":"J Endocr Soc"},{"issue":"29","key":"2748_CR49","doi-asserted-by":"publisher","first-page":"18304","DOI":"10.1074\/jbc.272.29.18304","volume":"272","author":"R Devos","year":"1997","unstructured":"Devos R, Guisez Y, Van der Heyden J, White DW, Kalai M, Fountoulakis M, et al. Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. J Biol Chem. 1997;272(29):18304\u201310.","journal-title":"J Biol Chem"},{"key":"2748_CR50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jchemneu.2014.09.002","volume":"61\u201362","author":"N Wada","year":"2014","unstructured":"Wada N, Hirako S, Takenoya F, Kageyama H, Okabe M, Shioda S. Leptin and its receptors. J Chem Neuroanat. 2014;61\u201362:191\u20139.","journal-title":"J Chem Neuroanat"},{"key":"2748_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fcimb.2018.00147","volume":"8","author":"D Alti","year":"2018","unstructured":"Alti D, Sambamurthy C, Kalangi SK. Emergence of leptin in infection and immunity: scope and challenges in vaccines formulation. Front Cell Infect Microbiol. 2018;8:147.","journal-title":"Front Cell Infect Microbiol"},{"issue":"14","key":"2748_CR52","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1096\/fj.01-0431rev","volume":"15","author":"R Faggioni","year":"2001","unstructured":"Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2001;15(14):2565\u201371.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"7","key":"2748_CR53","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","volume":"83","author":"LA Tartaglia","year":"1995","unstructured":"Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor. OB-R. Cell. 1995;83(7):1263\u201371.","journal-title":"Cell"},{"issue":"8","key":"2748_CR54","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0898-6568(02)00006-2","volume":"14","author":"G Sweeney","year":"2002","unstructured":"Sweeney G. Leptin signalling. Cell Signal. 2002;14(8):655\u201363.","journal-title":"Cell Signal"},{"issue":"3","key":"2748_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000054536","volume":"71","author":"B Burguera","year":"2000","unstructured":"Burguera B, Couce ME, Long J, Lamsam J, Laakso K, Jensen MD, et al. The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain. Neuroendocrinology. 2000;71(3):187\u201395.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2748_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000369678","volume":"35","author":"Y Nozhenko","year":"2015","unstructured":"Nozhenko Y, Rodr\u00edguez AM, Palou A. Leptin rapidly induces the expression of metabolic and myokine genes in C2C12 muscle cells to regulate nutrient partition and oxidation. Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol. 2015;35(1):92\u2013103.","journal-title":"Cell Physiol Biochemistry: Int J Experimental Cell Physiol Biochem Pharmacol"},{"issue":"4","key":"2748_CR57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.molmet.2013.07.007","volume":"2","author":"Z Li","year":"2013","unstructured":"Li Z, Ceccarini G, Eisenstein M, Tan K, Friedman JM. Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor. Mol Metab. 2013;2(4):364\u201375.","journal-title":"Mol Metab"},{"issue":"Suppl 2","key":"2748_CR58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/2047-783X-15-S2-50","volume":"15","author":"E Gorska","year":"2010","unstructured":"Gorska E, Popko K, Stelmaszczyk-Emmel A, Ciepiela O, Kucharska A, Wasik M. Leptin receptors. Eur J Med Res. 2010;15(Suppl 2):50\u20134.","journal-title":"Eur J Med Res"},{"issue":"4","key":"2748_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molmet.2013.09.001","volume":"2","author":"J Dam","year":"2013","unstructured":"Dam J, Jockers R. Hunting for the functions of short leptin receptor isoforms. Mol Metab. 2013;2(4):327\u20138.","journal-title":"Mol Metab"},{"issue":"7","key":"2748_CR60","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2337\/diabetes.51.7.2105","volume":"51","author":"JL Chan","year":"2002","unstructured":"Chan JL, Bl\u00fcher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes. 2002;51(7):2105\u201312.","journal-title":"Diabetes"},{"issue":"3","key":"2748_CR61","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","volume":"89","author":"GR Steinberg","year":"2009","unstructured":"Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009;89(3):1025\u201378.","journal-title":"Physiol Rev"},{"issue":"1\u20132","key":"2748_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellimm.2007.09.004","volume":"252","author":"R Lago","year":"2008","unstructured":"Lago R, G\u00f3mez R, Lago F, G\u00f3mez-Reino J, Gualillo O. Leptin beyond body weight regulation\u2013current concepts concerning its role in immune function and inflammation. Cell Immunol. 2008;252(1\u20132):139\u201345.","journal-title":"Cell Immunol"},{"key":"2748_CR63","doi-asserted-by":"publisher","first-page":"784343","DOI":"10.1155\/2010\/784343","volume":"2010","author":"N S\u00e1inz","year":"2010","unstructured":"S\u00e1inz N, Rodr\u00edguez A, Catal\u00e1n V, Becerril S, Ram\u00edrez B, G\u00f3mez-Ambrosi J, et al. Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob\/ob mice. Mediat Inflamm. 2010;2010:784343.","journal-title":"Mediat Inflamm"},{"key":"2748_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165887","author":"A P\u00e9rez-P\u00e9rez","year":"2020","unstructured":"P\u00e9rez-P\u00e9rez A, S\u00e1nchez-Jim\u00e9nez F, Vilari\u00f1o-Garc\u00eda T, S\u00e1nchez-Margalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21165887.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2748_CR65","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","volume":"18","author":"B Kirk","year":"2020","unstructured":"Kirk B, Feehan J, Lombardi G, Duque G. Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep. 2020;18(4):388\u2013400.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"2748_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnaa027","volume":"42","author":"S Pereira","year":"2021","unstructured":"Pereira S, Cline DL, Glavas MM, Covey SD, Kieffer TJ. Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev. 2021;42(1):1\u201328.","journal-title":"Endocr Rev"},{"issue":"17","key":"2748_CR67","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.4161\/cc.10.17.17067","volume":"10","author":"SA Malik","year":"2011","unstructured":"Malik SA, Mari\u00f1o G, BenYoun\u00e8s A, Shen S, Harper F, Maiuri MC, et al. Neuroendocrine regulation of autophagy by leptin. Cell Cycle. 2011;10(17):2917\u201323.","journal-title":"Cell Cycle"},{"issue":"11","key":"2748_CR68","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s001250050832","volume":"40","author":"M Kellerer","year":"1997","unstructured":"Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, H\u00e4ring HU. Leptin activates PI-3 kinase in C2C12 myotubes via Janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia. 1997;40(11):1358\u201362.","journal-title":"Diabetologia"},{"issue":"9","key":"2748_CR69","doi-asserted-by":"publisher","first-page":"e6808","DOI":"10.1371\/journal.pone.0006808","volume":"4","author":"N S\u00e1inz","year":"2009","unstructured":"S\u00e1inz N, Rodr\u00edguez A, Catal\u00e1n V, Becerril S, Ram\u00edrez B, G\u00f3mez-Ambrosi J, et al. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob\/ob mice. PLoS ONE. 2009;4(9):e6808.","journal-title":"PLoS ONE"},{"issue":"8","key":"2748_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072330","volume":"8","author":"P Arounleut","year":"2013","unstructured":"Arounleut P, Bowser M, Upadhyay S, Shi XM, Fulzele S, Johnson MH, et al. Absence of functional leptin receptor isoforms in the POUND (Lepr(db\/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS ONE. 2013;8(8):e72330.","journal-title":"PLoS ONE"},{"key":"2748_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12111962","author":"Y Potes","year":"2023","unstructured":"Potes Y, D\u00edaz-Luis A, Bermejo-Millo JC, P\u00e9rez-Mart\u00ednez Z, de Lux\u00e1n-Delgado B, Rubio-Gonz\u00e1lez A, et al. Melatonin alleviates the impairment of muscle bioenergetics and protein quality control systems in Leptin-Deficiency-Induced obesity. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12111962.","journal-title":"Antioxidants"},{"issue":"5\u20136","key":"2748_CR72","doi-asserted-by":"publisher","first-page":"e1700375","DOI":"10.1002\/pmic.201700375","volume":"18","author":"M Sch\u00f6nke","year":"2018","unstructured":"Sch\u00f6nke M, Bj\u00f6rnholm M, Chibalin AV, Zierath JR, Deshmukh AS. Proteomics analysis of skeletal muscle from Leptin-deficient ob\/ob mice reveals adaptive remodeling of metabolic characteristics and fiber type composition. Proteomics. 2018;18(5\u20136):e1700375.","journal-title":"Proteomics"},{"issue":"2\u20133","key":"2748_CR73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.wneu.2010.02.019","volume":"74","author":"XQ Dong","year":"2010","unstructured":"Dong XQ, Huang M, Hu YY, Yu WH, Zhang ZY. Time course of plasma leptin concentrations after acute spontaneous basal ganglia hemorrhage. World Neurosurg. 2010;74(2\u20133):286\u201393.","journal-title":"World Neurosurg"},{"issue":"4","key":"2748_CR74","first-page":"565","volume":"20","author":"M Tzanela","year":"2006","unstructured":"Tzanela M, Orfanos SE, Tsirantonaki M, Kotanidou A, Sotiropoulou C, Christophoraki M, et al. Leptin alterations in the course of sepsis in humans. In vivo (Athens, Greece). 2006;20(4):565\u201370.","journal-title":"In vivo (Athens, Greece)"},{"issue":"1","key":"2748_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-10-13","volume":"10","author":"K Rajendran","year":"2012","unstructured":"Rajendran K, Devarajan N, Ganesan M, Ragunathan M. Obesity. Inflammation and acute myocardial infarction - expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population. Thromb J. 2012;10(1):13.","journal-title":"Thromb J"},{"key":"2748_CR76","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2334-12-217","volume":"12","author":"M Behnes","year":"2012","unstructured":"Behnes M, Brueckmann M, Lang S, Putensen C, Saur J, Borggrefe M, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis. 2012;12:217.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2748_CR77","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2265.2001.01209.x","volume":"54","author":"ED Papathanassoglou","year":"2001","unstructured":"Papathanassoglou ED, Moynihan JA, Ackerman MH, Mantzoros CS. Serum leptin levels are higher but are not independently associated with severity or mortality in the multiple organ dysfunction\/systemic inflammatory response syndrome: a matched case control and a longitudinal study. Clin Endocrinol. 2001;54(2):225\u201333.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2748_CR78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.33549\/physiolres.931523","volume":"58","author":"P Maruna","year":"2009","unstructured":"Maruna P, Lindner J, Kubzov\u00e1 KM. Leptin and soluble leptin receptor changes after pulmonary endarterectomy: relations to cortisol and cytokine network. Physiol Res. 2009;58(4):569\u201376.","journal-title":"Physiol Res"},{"issue":"8","key":"2748_CR79","first-page":"880","volume":"87","author":"I Karampela","year":"2021","unstructured":"Karampela I, Chrysanthopoulou E, Skyllas G, Christodoulatos GS, Kandri E, Antonakos G, et al. Circulating leptin, soluble leptin receptor and free leptin index in critically ill patients with sepsis: a prospective observational study. Minerva Anestesiol. 2021;87(8):880\u201390.","journal-title":"Minerva Anestesiol"},{"key":"2748_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","volume":"98","author":"A La Cava","year":"2017","unstructured":"La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51\u20138.","journal-title":"Cytokine"},{"key":"2748_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111931","volume":"168","author":"Z Liang","year":"2022","unstructured":"Liang Z, Zhang T, Liu H, Li Z, Peng L, Wang C, et al. Inflammaging: the ground for sarcopenia? Exp Gerontol. 2022;168:111931.","journal-title":"Exp Gerontol"},{"issue":"2","key":"2748_CR82","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/cc8911","volume":"14","author":"AA Yousef","year":"2010","unstructured":"Yousef AA, Amr YM, Suliman GA. The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study. Crit Care (London England). 2010;14(2):R33.","journal-title":"Crit Care (London England)"},{"issue":"1","key":"2748_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12891-019-2581-5","volume":"20","author":"R Tazawa","year":"2019","unstructured":"Tazawa R, Uchida K, Fujimaki H, Miyagi M, Inoue G, Sekiguchi H, et al. Elevated leptin levels induce inflammation through IL-6 in skeletal muscle of aged female rats. BMC Musculoskelet Disord. 2019;20(1):199.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"2748_CR84","doi-asserted-by":"publisher","first-page":"e08491","DOI":"10.1016\/j.heliyon.2021.e08491","volume":"7","author":"EA Polyakova","year":"2021","unstructured":"Polyakova EA, Mikhaylov EN, Galagudza MM, Shlyakhto EV. Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury. Heliyon. 2021;7(11):e08491.","journal-title":"Heliyon"},{"issue":"1\u20132","key":"2748_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2014.07.014","volume":"345","author":"E Witteveen","year":"2014","unstructured":"Witteveen E, Wieske L, Verhamme C, Schultz MJ, van Schaik IN, Horn J. Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review. J Neurol Sci. 2014;345(1\u20132):15\u201325.","journal-title":"J Neurol Sci"},{"issue":"6588","key":"2748_CR86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/382250a0","volume":"382","author":"RS Ahima","year":"1996","unstructured":"Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250\u20132.","journal-title":"Nature"},{"issue":"1","key":"2748_CR87","first-page":"39","volume":"80","author":"E Parmentier-Decrucq","year":"2014","unstructured":"Parmentier-Decrucq E, Nseir S, Makris D, Desrousseaux B, Soudan B, Favory R, et al. Accuracy of leptin serum level in diagnosing ventilator-associated pneumonia: a case-control study. Minerva Anestesiol. 2014;80(1):39\u201347.","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"2748_CR88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/db23-0571","volume":"73","author":"S Zhao","year":"2024","unstructured":"Zhao S, Li N, Xiong W, Li G, He S, Zhang Z, et al. Leptin reduction as a required component for weight loss. Diabetes. 2024;73(2):197\u2013210.","journal-title":"Diabetes"},{"issue":"1","key":"2748_CR89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/me.2015-1232","volume":"30","author":"JN Flak","year":"2016","unstructured":"Flak JN, Myers MG. Jr. Minireview: CNS mechanisms of leptin action. Molecular endocrinology. (Baltimore Md). 2016;30(1):3\u201312.","journal-title":"(Baltimore Md)"},{"issue":"3","key":"2748_CR90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5492\/wjccm.v12.i3.139","volume":"12","author":"W Nedel","year":"2023","unstructured":"Nedel W, Deutschendorf C, Portela LVC. Sepsis-induced mitochondrial dysfunction: a narrative review. World J Crit Care Med. 2023;12(3):139\u201352.","journal-title":"World J Crit Care Med"},{"issue":"9","key":"2748_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14229","volume":"54","author":"F Galli","year":"2024","unstructured":"Galli F, Bartolini D, Ronco C. Oxidative stress, defective proteostasis and immunometabolic complications in critically ill patients. Eur J Clin Invest. 2024;54(9):e14229.","journal-title":"Eur J Clin Invest"},{"issue":"19","key":"2748_CR92","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G van den Berghe","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359\u201367.","journal-title":"N Engl J Med"},{"key":"2748_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1099143","volume":"10","author":"X Xu","year":"2023","unstructured":"Xu X, Talifu Z, Zhang CJ, Gao F, Ke H, Pan YZ, et al. Mechanism of skeletal muscle atrophy after spinal cord injury: a narrative review. Front Nutr. 2023;10:1099143.","journal-title":"Front Nutr"},{"issue":"6696","key":"2748_CR94","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/29795","volume":"394","author":"GM Lord","year":"1998","unstructured":"Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897\u2013901.","journal-title":"Nature"},{"issue":"1","key":"2748_CR95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/cimm.1999.1594","volume":"199","author":"C Mart\u00edn-Romero","year":"2000","unstructured":"Mart\u00edn-Romero C, Santos-Alvarez J, Goberna R, S\u00e1nchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199(1):15\u201324.","journal-title":"Cell Immunol"},{"key":"2748_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622468","volume":"11","author":"K Kiernan","year":"2020","unstructured":"Kiernan K, MacIver NJ. The role of the adipokine leptin in immune cell function in health and disease. Front Immunol. 2020;11:622468.","journal-title":"Front Immunol"},{"key":"2748_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.dci.2016.06.006","volume":"66","author":"C Procaccini","year":"2017","unstructured":"Procaccini C, La Rocca C, Carbone F, De Rosa V, Galgani M, Matarese G. Leptin as immune mediator: interaction between neuroendocrine and immune system. Dev Comp Immunol. 2017;66:120\u20139.","journal-title":"Dev Comp Immunol"},{"issue":"1","key":"2748_CR98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mam.2011.10.012","volume":"33","author":"C Procaccini","year":"2012","unstructured":"Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med. 2012;33(1):35\u201345.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"2748_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"key":"2748_CR100","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cyto.2016.08.033","volume":"88","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang H, Yin YL, Guo WZ, Ma YQ, Wang YB, et al. Role of interleukin-6 to differentiate sepsis from non-infectious systemic inflammatory response syndrome. Cytokine. 2016;88:126\u201335.","journal-title":"Cytokine"},{"issue":"3","key":"2748_CR101","doi-asserted-by":"publisher","first-page":"e18090","DOI":"10.1371\/journal.pone.0018090","volume":"6","author":"JG Jespersen","year":"2011","unstructured":"Jespersen JG, Nedergaard A, Reitelseder S, Mikkelsen UR, Dideriksen KJ, Agergaard J, et al. Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients. PLoS ONE. 2011;6(3):e18090.","journal-title":"PLoS ONE"},{"issue":"9","key":"2748_CR102","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1590\/S0004-27302012000900001","volume":"56","author":"G Paz-Filho","year":"2012","unstructured":"Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong ML, Licinio J. Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol. 2012;56(9):597\u2013607.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6","key":"2748_CR103","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","volume":"9","author":"OJ McElvaney","year":"2021","unstructured":"McElvaney OJ, Curley GF, Rose-John S, McElvaney NG. Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021;9(6):643\u201354.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2748_CR104","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00134-024-07388-6","volume":"50","author":"NE Brummel","year":"2024","unstructured":"Brummel NE, Hughes CG, McNeil JB, Pandharipande PP, Thompson JL, Orun OM, et al. Systemic inflammation and delirium during critical illness. Intensive Care Med. 2024;50(5):687\u201396.","journal-title":"Intensive Care Med"},{"key":"2748_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20236008.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2748_CR106","first-page":"517","volume":"185","author":"NI Shapiro","year":"1950","unstructured":"Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, et al. Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol\u00a0(Baltimore, Md\u202f: 1950). 1950;185(1):517\u201324.","journal-title":"J Immunol\u00a0(Baltimore, Md : 1950)"},{"issue":"22","key":"2748_CR107","doi-asserted-by":"publisher","first-page":"13471","DOI":"10.18632\/aging.205254","volume":"15","author":"KV Chang","year":"2023","unstructured":"Chang KV, Wu WT, Chen YH, Chen LR, Hsu WH, Lin YL, et al. Enhanced serum levels of tumor necrosis factor-\u03b1, interleukin-1\u03b2, and \u2013 6 in sarcopenia: alleviation through exercise and nutrition intervention. Aging. 2023;15(22):13471\u201385.","journal-title":"Aging"},{"key":"2748_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","volume":"1088","author":"A Thoma","year":"2018","unstructured":"Thoma A, Lightfoot AP. NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. Adv Exp Med Biol. 2018;1088:267\u201379.","journal-title":"Adv Exp Med Biol"},{"issue":"1\u20132","key":"2748_CR109","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0165-5728(99)00252-0","volume":"106","author":"MA De Letter","year":"2000","unstructured":"De Letter MA, van Doorn PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol. 2000;106(1\u20132):206\u201313.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2748_CR110","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-003-0704-3","volume":"106","author":"F Fenzi","year":"2003","unstructured":"Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol. 2003;106(1):75\u201382.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2748_CR111","doi-asserted-by":"publisher","first-page":"e92048","DOI":"10.1371\/journal.pone.0092048","volume":"9","author":"C Langhans","year":"2014","unstructured":"Langhans C, Weber-Carstens S, Schmidt F, Hamati J, Kny M, Zhu X, et al. Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS ONE. 2014;9(3):e92048.","journal-title":"PLoS ONE"},{"issue":"11","key":"2748_CR112","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1249\/MSS.0000000000000975","volume":"48","author":"SK Powers","year":"2016","unstructured":"Powers SK, Lynch GS, Murphy KT, Reid MB, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med Sci Sports Exerc. 2016;48(11):2307\u201319.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"2748_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/cc9074","volume":"14","author":"S Weber-Carstens","year":"2010","unstructured":"Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14(3):R119.","journal-title":"Crit Care"},{"issue":"4","key":"2748_CR114","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00134-014-3224-9","volume":"40","author":"T Wollersheim","year":"2014","unstructured":"Wollersheim T, Woehlecke J, Krebs M, Hamati J, Lodka D, Luther-Schroeder A, et al. Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med. 2014;40(4):528\u201338.","journal-title":"Intensive Care Med"},{"issue":"4","key":"2748_CR115","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007\u201323.","journal-title":"Immunity"},{"key":"2748_CR116","first-page":"53","volume":"11","author":"P Plomgaard","year":"2005","unstructured":"Plomgaard P, Penkowa M, Pedersen BK. Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. Exerc Immunol Rev. 2005;11:53\u201363.","journal-title":"Exerc Immunol Rev"},{"key":"2748_CR117","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190347","author":"S Kang","year":"2020","unstructured":"Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20190347.","journal-title":"J Exp Med"},{"issue":"5","key":"2748_CR118","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357.","journal-title":"Nat Immunol"},{"issue":"4","key":"2748_CR119","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami M, Kamimura D, Hirano T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity. 2019;50(4):812\u201331.","journal-title":"Immunity"},{"issue":"5","key":"2748_CR120","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878\u201388.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2748_CR121","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","volume":"98","author":"F Haddad","year":"2005","unstructured":"Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol. 2005;98(3):911\u20137.","journal-title":"J Appl Physiol"},{"key":"2748_CR122","doi-asserted-by":"publisher","first-page":"206026","DOI":"10.1155\/2014\/206026","volume":"2014","author":"M Pelosi","year":"2014","unstructured":"Pelosi M, De Rossi M, Barberi L, Musar\u00f2 A. IL-6 impairs myogenic differentiation by downmodulation of p90RSK\/eEF2 and mTOR\/p70S6K axes, without affecting AKT activity. Biomed Res Int. 2014;2014:206026.","journal-title":"Biomed Res Int"},{"issue":"10","key":"2748_CR123","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2748_CR124","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jcsm.12867","volume":"13","author":"L Zanders","year":"2022","unstructured":"Zanders L, Kny M, Hahn A, Schmidt S, Wundersitz S, Todiras M, et al. Sepsis induces Interleukin 6, gp130\/JAK2\/STAT3, and muscle wasting. J Cachexia Sarcopenia Muscle. 2022;13(1):713\u201327.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2748_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.05.001","volume":"41","author":"L Forcina","year":"2018","unstructured":"Forcina L, Miano C, Musar\u00f2 A. The physiopathologic interplay between stem cells and tissue niche in muscle regeneration and the role of IL-6 on muscle homeostasis and diseases. Cytokine Growth Factor Rev. 2018;41:1\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"2748_CR126","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nri1664","volume":"5","author":"SM Allan","year":"2005","unstructured":"Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5(8):629\u201340.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2748_CR127","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/SPC.0000000000000398","volume":"12","author":"JJ McDonald","year":"2018","unstructured":"McDonald JJ, McMillan DC, Laird BJA. Targeting IL-1\u03b1 in cancer cachexia: a narrative review. Curr Opin Support Palliat Care. 2018;12(4):453\u20139.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"4","key":"2748_CR128","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00024382-199904000-00002","volume":"11","author":"RN Cooney","year":"1999","unstructured":"Cooney RN, Maish GO 3rd, Gilpin T, Shumate ML, Lang CH, Vary TC. Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle. Shock. 1999;11(4):235\u201341.","journal-title":"Shock"},{"issue":"10","key":"2748_CR129","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJM198303103081002","volume":"308","author":"V Baracos","year":"1983","unstructured":"Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308(10):553\u20138.","journal-title":"N Engl J Med"},{"issue":"3 Pt 1","key":"2748_CR130","first-page":"E513","volume":"271","author":"TC Vary","year":"1996","unstructured":"Vary TC, Voisin L, Cooney RN. Regulation of peptide-chain initiation in muscle during sepsis by interleukin-1 receptor antagonist. Am J Physiol. 1996;271(3 Pt 1):E513-20.","journal-title":"Am J Physiol"},{"issue":"12 Suppl","key":"2748_CR131","doi-asserted-by":"publisher","first-page":"S460","DOI":"10.1097\/01.CCM.0000185500.11080.91","volume":"33","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA. Interleukin-1beta. Crit Care Med. 2005;33(12 Suppl):S460-2.","journal-title":"Crit Care Med"},{"issue":"4","key":"2748_CR132","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00024382-199504000-00001","volume":"3","author":"JH Pruitt","year":"1995","unstructured":"Pruitt JH, Copeland EM 3rd, Moldawer LL. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock. 1995;3(4):235\u201351.","journal-title":"Shock"},{"issue":"2","key":"2748_CR133","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/0885066606297123","volume":"22","author":"E Jean-Baptiste","year":"2007","unstructured":"Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med. 2007;22(2):63\u201372.","journal-title":"J Intensive Care Med"},{"issue":"Suppl 1","key":"2748_CR134","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/BF02390680","volume":"13","author":"M van Deuren","year":"1994","unstructured":"van Deuren M. Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, Interleukin 1-beta and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 1994;13(Suppl 1):S12\u20136.","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"issue":"6","key":"2748_CR135","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/jcsm.12763","volume":"12","author":"K Busch","year":"2021","unstructured":"Busch K, Kny M, Huang N, Klassert TE, Stock M, Hahn A, et al. Inhibition of the NLRP3\/IL-1\u03b2 axis protects against sepsis-induced cardiomyopathy. J Cachexia Sarcopenia Muscle. 2021;12(6):1653\u201368.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2748_CR136","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.abb.2003.12.008","volume":"423","author":"R Brigelius-Floh\u00e9","year":"2004","unstructured":"Brigelius-Floh\u00e9 R, Banning A, Kny M, B\u00f6l GF. Redox events in interleukin-1 signaling. Arch Biochem Biophys. 2004;423(1):66\u201373.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"2748_CR137","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(98)00216-X","volume":"133","author":"M Llovera","year":"1998","unstructured":"Llovera M, Carb\u00f3 N, L\u00f3pez-Soriano J, Garc\u00eda-Mart\u00ednez C, Busquets S, Alvarez B, et al. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett. 1998;133(1):83\u20137.","journal-title":"Cancer Lett"},{"issue":"5547","key":"2748_CR138","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294(5547):1704\u20138.","journal-title":"Science"},{"issue":"1","key":"2748_CR139","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40635-016-0115-0","volume":"5","author":"N Huang","year":"2017","unstructured":"Huang N, Kny M, Riediger F, Busch K, Schmidt S, Luft FC, et al. Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy. Intensive Care Med Exp. 2017;5(1):3.","journal-title":"Intensive Care Med Exp"},{"issue":"9","key":"2748_CR140","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1210\/en.2007-0017","volume":"148","author":"JM Scarlett","year":"2007","unstructured":"Scarlett JM, Jobst EE, Enriori PJ, Bowe DD, Batra AK, Grant WF, et al. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology. 2007;148(9):4217\u201325.","journal-title":"Endocrinology"},{"issue":"3","key":"2748_CR141","doi-asserted-by":"publisher","first-page":"C706","DOI":"10.1152\/ajpcell.00626.2008","volume":"297","author":"W Li","year":"2009","unstructured":"Li W, Moylan JS, Chambers MA, Smith J, Reid MB. Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol. 2009;297(3):C706-14.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2748_CR142","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1523\/JNEUROSCI.14-02-00897.1994","volume":"14","author":"A Ericsson","year":"1994","unstructured":"Ericsson A, Kov\u00e1cs KJ, Sawchenko PE. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neuroscience: Official J Soc Neurosci. 1994;14(2):897\u2013913.","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"12","key":"2748_CR143","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20111020","volume":"208","author":"TP Braun","year":"2011","unstructured":"Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, Levasseur PR, et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med. 2011;208(12):2449\u201363.","journal-title":"J Exp Med"},{"issue":"5 Pt 1","key":"2748_CR144","first-page":"E636","volume":"267","author":"R Cooney","year":"1994","unstructured":"Cooney R, Owens E, Jurasinski C, Gray K, Vannice J, Vary T. Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis. Am J Physiol. 1994;267(5 Pt 1):E636-41.","journal-title":"Am J Physiol"},{"issue":"9","key":"2748_CR145","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0026-0495(03)00161-6","volume":"52","author":"CE Lloyd","year":"2003","unstructured":"Lloyd CE, Palopoli M, Vary TC. Effect of central administration of interleukin-1 receptor antagonist on protein synthesis in skeletal muscle, kidney, and liver during sepsis. Metabolism. 2003;52(9):1218\u201325.","journal-title":"Metabolism"},{"key":"2748_CR146","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0083-6729(06)74013-4","volume":"74","author":"RN Cooney","year":"2006","unstructured":"Cooney RN, Shumate M. The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness. Vitam Horm. 2006;74:317\u201340.","journal-title":"Vitam Horm"},{"key":"2748_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","author":"DI Jang","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22052719.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2748_CR148","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1152\/japplphysiol.00898.2007","volume":"104","author":"BJ Hardin","year":"2008","unstructured":"Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, et al. TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol (1985). 2008;104(3):694\u20139.","journal-title":"J Appl Physiol (1985)"},{"key":"2748_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152397","author":"I Stratos","year":"2022","unstructured":"Stratos I, Behrendt AK, Anselm C, Gonzalez A, Mittlmeier T, Vollmar B. Inhibition of TNF-\u03b1 restores muscle force, inhibits inflammation, and reduces apoptosis of traumatized skeletal muscles. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11152397.","journal-title":"Cells"},{"issue":"10","key":"2748_CR150","first-page":"871","volume":"12","author":"YP Li","year":"1998","unstructured":"Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 1998;12(10):871\u201380.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"4","key":"2748_CR151","doi-asserted-by":"publisher","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","volume":"279","author":"YP Li","year":"2000","unstructured":"Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1165-70.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"2748_CR152","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/j.1460-2075.1996.tb00524.x","volume":"15","author":"M Buck","year":"1996","unstructured":"Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 1996;15(8):1753\u201365.","journal-title":"EMBO J"},{"issue":"3","key":"2748_CR153","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0014-5793(93)81341-V","volume":"323","author":"C Garc\u00eda-Mart\u00ednez","year":"1993","unstructured":"Garc\u00eda-Mart\u00ednez C, Agell N, Llovera M, L\u00f3pez-Soriano FJ, Argil\u00e9s JM. Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 1993;323(3):211\u20134.","journal-title":"FEBS Lett"},{"key":"2748_CR154","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/B978-0-12-385940-2.00004-8","volume":"96","author":"JM Peterson","year":"2011","unstructured":"Peterson JM, Bakkar N, Guttridge DC. NF-\u03baB signaling in skeletal muscle health and disease. Curr Top Dev Biol. 2011;96:85\u2013119.","journal-title":"Curr Top Dev Biol"},{"issue":"3","key":"2748_CR155","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1006\/bbrc.1997.7206","volume":"237","author":"CK Sen","year":"1997","unstructured":"Sen CK, Khanna S, Reznick AZ, Roy S, Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun. 1997;237(3):645\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2748_CR156","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1096\/fj.04-2364com","volume":"19","author":"YP Li","year":"2005","unstructured":"Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2005;19(3):362\u201370.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"2","key":"2748_CR157","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1152\/ajpendo.00366.2001","volume":"282","author":"CH Lang","year":"2002","unstructured":"Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab. 2002;282(2):E336-47.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2748_CR158","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1164\/ajrccm.153.5.8630610","volume":"153","author":"P Wilcox","year":"1996","unstructured":"Wilcox P, Milliken C, Bressler B. High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor. Am J Respir Crit Care Med. 1996;153(5):1611\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2748_CR159","doi-asserted-by":"publisher","first-page":"R2156","DOI":"10.1152\/ajpregu.2000.279.6.R2156","volume":"279","author":"G Alloatti","year":"2000","unstructured":"Alloatti G, Penna C, Mariano F, Camussi G. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol Regul Integr Comp Physiol. 2000;279(6):R2156-63.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"2748_CR160","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1164\/rccm.2202005","volume":"166","author":"MB Reid","year":"2002","unstructured":"Reid MB, L\u00e4nnergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002;166(4):479\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"2748_CR161","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1161\/01.CIR.102.14.1690","volume":"102","author":"X Li","year":"2000","unstructured":"Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr., Sivasubramanian N, et al. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation. 2000;102(14):1690\u20136.","journal-title":"Circulation"},{"issue":"3","key":"2748_CR162","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jmb.2010.06.017","volume":"401","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Low A, Sharpe TD, Uppenberg J, Yao S, Kuang Z, et al. Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4. J Mol Biol. 2010;401(3):389\u2013402.","journal-title":"J Mol Biol"},{"issue":"29","key":"2748_CR163","doi-asserted-by":"publisher","first-page":"17894","DOI":"10.1074\/jbc.M114.607184","volume":"290","author":"S Liu","year":"2015","unstructured":"Liu S, Nheu T, Luwor R, Nicholson SE, Zhu HJ. SPSB1, a novel negative regulator of the transforming growth factor-\u03b2 signaling pathway targeting the type II receptor. J Biol Chem. 2015;290(29):17894\u2013908.","journal-title":"J Biol Chem"},{"issue":"1","key":"2748_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0223-4","volume":"16","author":"S Liu","year":"2018","unstructured":"Liu S, Iaria J, Simpson RJ, Zhu HJ. Ras enhances TGF-\u03b2 signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1. Cell Commun Signal. 2018;16(1):10.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"2748_CR165","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/jcsm.13252","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, D\u00f6rmann N, Brinschwitz B, Kny M, Martin E, Bartels K, et al. SPSB1-mediated inhibition of TGF-\u03b2 receptor-II impairs myogenesis in inflammation. J Cachexia Sarcopenia Muscle. 2023;14(4):1721\u201336.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2748_CR166","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-981-13-1286-1_8","volume":"1090","author":"J Liu","year":"2018","unstructured":"Liu J, Yang X, Yu S, Zheng R. The leptin resistance. Adv Exp Med Biol. 2018;1090:145\u201363.","journal-title":"Adv Exp Med Biol"},{"key":"2748_CR167","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/978-3-031-63657-8_16","volume":"1460","author":"A Engin","year":"2024","unstructured":"Engin A. The mechanism of leptin resistance in obesity and therapeutic perspective. Adv Exp Med Biol. 2024;1460:463\u201387.","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"2748_CR168","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm1071","volume":"10","author":"H Mori","year":"2004","unstructured":"Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med. 2004;10(7):739\u201343.","journal-title":"Nat Med"},{"key":"2748_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095202","author":"JA Flores-Cordero","year":"2022","unstructured":"Flores-Cordero JA, P\u00e9rez-P\u00e9rez A, Jim\u00e9nez-Cortegana C, Alba G, Flores-Barrag\u00e1n A, S\u00e1nchez-Margalet V. Obesity as a risk factor for dementia and Alzheimer\u2019s disease: the role of leptin. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23095202.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2748_CR170","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.tips.2015.07.003","volume":"36","author":"ZY Zhang","year":"2015","unstructured":"Zhang ZY, Dodd GT, Tiganis T. Protein tyrosine phosphatases in hypothalamic insulin and leptin signaling. Trends Pharmacol Sci. 2015;36(10):661\u201374.","journal-title":"Trends Pharmacol Sci"},{"key":"2748_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2021.105006","volume":"133","author":"J Peng","year":"2021","unstructured":"Peng J, Yin L, Wang X. Central and peripheral leptin resistance in obesity and improvements of exercise. Horm Behav. 2021;133:105006.","journal-title":"Horm Behav"},{"issue":"2","key":"2748_CR172","first-page":"89","volume":"40","author":"AR Lubis","year":"2008","unstructured":"Lubis AR, Widia F, Soegondo S, Setiawati A. The role of SOCS-3 protein in leptin resistance and obesity. Acta Med Indones. 2008;40(2):89\u201395.","journal-title":"Acta Med Indones"},{"key":"2748_CR173","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-981-13-1435-3_9","volume":"1088","author":"AI Mart\u00edn","year":"2018","unstructured":"Mart\u00edn AI, Priego T, L\u00f3pez-Calder\u00f3n A. Hormones and Muscle Atrophy. Advances in experimental medicine and biology. 2018;1088:207\u2009\u2013\u200933.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2748_CR174","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00421-013-2779-4","volume":"114","author":"B Guerra","year":"2014","unstructured":"Guerra B, Ponce-Gonz\u00e1lez JG, Morales-Alamo D, Guadalupe-Grau A, Kiilerich K, Fuentes T, et al. Leptin signaling in skeletal muscle after bed rest in healthy humans. Eur J Appl Physiol. 2014;114(2):345\u201357.","journal-title":"Eur J Appl Physiol"},{"issue":"42","key":"2748_CR175","doi-asserted-by":"publisher","first-page":"30059","DOI":"10.1074\/jbc.274.42.30059","volume":"274","author":"C Bj\u00f8rbaek","year":"1999","unstructured":"Bj\u00f8rbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999;274(42):30059\u201365.","journal-title":"J Biol Chem"},{"issue":"169","key":"2748_CR176","first-page":"Pe6","volume":"2003","author":"DL Krebs","year":"2003","unstructured":"Krebs DL, Hilton DJ. A new role for SOCS in insulin action. Suppressor of cytokine signaling. Science\u2019s STKE: Signal Transduct Knowl Environ. 2003;2003(169):Pe6.","journal-title":"Science\u2019s STKE: Signal Transduct Knowl Environ"},{"issue":"3","key":"2748_CR177","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcb.23420","volume":"113","author":"N Al-Shanti","year":"2012","unstructured":"Al-Shanti N, Stewart CE. Inhibitory effects of IL-6 on IGF-1 activity in skeletal myoblasts could be mediated by the activation of SOCS-3. J Cell Biochem. 2012;113(3):923\u201333.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2748_CR178","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1254\/fpj.23040","volume":"159","author":"K Sakamoto","year":"2024","unstructured":"Sakamoto K, Kurokawa J. Pathophysiology of skeletal muscle during sepsis. Folia Pharmacol Jpn. 2024;159(2):112\u20137.","journal-title":"Folia Pharmacol Jpn"},{"issue":"2","key":"2748_CR179","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1017\/S0007114512004849","volume":"110","author":"X Mao","year":"2013","unstructured":"Mao X, Zeng X, Huang Z, Wang J, Qiao S. Leptin and leucine synergistically regulate protein metabolism in C2C12 myotubes and mouse skeletal muscles. Br J Nutr. 2013;110(2):256\u201364.","journal-title":"Br J Nutr"},{"issue":"1\u20132","key":"2748_CR180","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0303-7207(02)00427-6","volume":"201","author":"P Maroni","year":"2003","unstructured":"Maroni P, Bendinelli P, Piccoletti R. Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol. 2003;201(1\u20132):109\u201321.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"2748_CR181","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cellbi.2005.03.008","volume":"29","author":"P Maroni","year":"2005","unstructured":"Maroni P, Bendinelli P, Piccoletti R. Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int. 2005;29(7):542\u201350.","journal-title":"Cell Biol Int"},{"issue":"1","key":"2748_CR182","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ghir.2004.11.001","volume":"15","author":"T Shavlakadze","year":"2005","unstructured":"Shavlakadze T, Winn N, Rosenthal N, Grounds MD. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm IGF Res. 2005;15(1):4\u201318.","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"2748_CR183","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1359\/jbmr.080213","volume":"23","author":"MW Hamrick","year":"2008","unstructured":"Hamrick MW, Ding KH, Ponnala S, Ferrari SL, Isales CM. Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight. J Bone Miner Res. 2008;23(6):870\u20138.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2748_CR184","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/er.2009-0010","volume":"30","author":"C Ohlsson","year":"2009","unstructured":"Ohlsson C, Mohan S, Sj\u00f6gren K, Tivesten A, Isgaard J, Isaksson O, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30(5):494\u2013535.","journal-title":"Endocr Rev"},{"issue":"1","key":"2748_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03236-y","volume":"21","author":"A Bian","year":"2020","unstructured":"Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020;21(1):214.","journal-title":"BMC Musculoskelet Disord"},{"key":"2748_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091970","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9091970.","journal-title":"Cells"},{"issue":"5","key":"2748_CR187","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1210\/endo.138.5.5238","volume":"138","author":"E Carro","year":"1997","unstructured":"Carro E, Se\u00f1aris R, Considine RV, Casanueva FF, Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology. 1997;138(5):2203\u20136.","journal-title":"Endocrinology"},{"key":"2748_CR188","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.exger.2015.07.014","volume":"70","author":"MW Hamrick","year":"2015","unstructured":"Hamrick MW, Dukes A, Arounleut P, Davis C, Periyasamy-Thandavan S, Mork S, et al. The adipokine leptin mediates muscle- and liver-derived IGF-1 in aged mice. Exp Gerontol. 2015;70:92\u20136.","journal-title":"Exp Gerontol"},{"issue":"2","key":"2748_CR189","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-17-0002","volume":"233","author":"S Lee","year":"2017","unstructured":"Lee S, Dong HH. Foxo integration of insulin signaling with glucose and lipid metabolism. J Endocrinol. 2017;233(2):R67-79.","journal-title":"J Endocrinol"},{"issue":"16","key":"2748_CR190","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/onc.2008.21","volume":"27","author":"DR Calnan","year":"2008","unstructured":"Calnan DR, Brunet A. The FoxO code. Oncogene. 2008;27(16):2276\u201388.","journal-title":"Oncogene"},{"key":"2748_CR191","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","volume":"127","author":"AK Brown","year":"2018","unstructured":"Brown AK, Webb AE. Regulation of FOXO factors in mammalian cells. Curr Top Dev Biol. 2018;127:165\u201392.","journal-title":"Curr Top Dev Biol"},{"key":"2748_CR192","first-page":"1","volume":"1890","author":"W Link","year":"2019","unstructured":"Link W. Introduction to FOXO biology. Methods in molecular biology. (Clifton NJ). 2019;1890:1\u20139.","journal-title":"(Clifton NJ)"},{"issue":"44","key":"2748_CR193","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1073\/pnas.0607795103","volume":"103","author":"M Sandri","year":"2006","unstructured":"Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA. 2006;103(44):16260\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2748_CR194","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1152\/japplphysiol.01313.2006","volume":"102","author":"B Guerra","year":"2007","unstructured":"Guerra B, Santana A, Fuentes T, Delgado-Guerra S, Cabrera-Socorro A, Dorado C, et al. Leptin receptors in human skeletal muscle. J Appl Physiol. 2007;102(5):1786\u201392.","journal-title":"J Appl Physiol"},{"issue":"7","key":"2748_CR195","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00018-016-2133-1","volume":"73","author":"O Kwon","year":"2016","unstructured":"Kwon O, Kim KW, Kim MS. Leptin signalling pathways in hypothalamic neurons. Cell Mol Life Sci. 2016;73(7):1457\u201377.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"2748_CR196","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 1999;96(6):857\u201368.","journal-title":"Cell"},{"key":"2748_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179687","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu X, Xu M, Yue T, Ling P, Fang T, et al. Comparative proteomic analysis of liver tissues and serum in db\/db mice. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179687.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2748_CR198","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1096\/fj.11-189977","volume":"26","author":"SA Reed","year":"2012","unstructured":"Reed SA, Sandesara PB, Senf SM, Judge AR. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2012;26(3):987\u20131000.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"18","key":"2748_CR199","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell. 2021;81(18):3677\u201390.","journal-title":"Mol Cell"},{"issue":"2","key":"2748_CR200","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2748_CR201","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025932118","author":"JC Drake","year":"2021","unstructured":"Drake JC, Wilson RJ, Laker RC, Guan Y, Spaulding HR, Nichenko AS, et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2025932118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2748_CR202","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103125","author":"DM Thomson","year":"2018","unstructured":"Thomson DM. The role of AMPK in the regulation of skeletal muscle size, hypertrophy, and regeneration. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19103125.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2748_CR203","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1152\/ajpendo.00261.2023","volume":"326","author":"JJ Petrocelli","year":"2024","unstructured":"Petrocelli JJ, Liu J, Yee EM, Ferrara PJ, Bourrant PE, de Hart N, et al. Skeletal muscle-specific inducible AMPK\u03b11\/\u03b12 knockout mice develop muscle weakness, glycogen depletion, and fibrosis that persists during disuse atrophy. Am J Physiol Endocrinol Metabolism. 2024;326(1):E50\u201360.","journal-title":"Am J Physiol Endocrinol Metabolism"},{"issue":"10","key":"2748_CR204","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.ijo.0803025","volume":"29","author":"RB Ceddia","year":"2005","unstructured":"Ceddia RB. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (2005). 2005;29(10):1175\u201383.","journal-title":"Int J Obes (2005)"},{"key":"2748_CR205","doi-asserted-by":"publisher","DOI":"10.12703\/P6-73","volume":"6","author":"HK Park","year":"2014","unstructured":"Park HK, Ahima RS. Leptin signaling. F1000prime reports. 2014;6:73.","journal-title":"F1000prime reports"},{"key":"2748_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065516","author":"F Klawitter","year":"2023","unstructured":"Klawitter F, Ehler J, Bajorat R, Patejdl R. Mitochondrial dysfunction in intensive care unit-acquired weakness and critical illness myopathy: a narrative review. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065516.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2748_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-01038-0","volume":"12","author":"G Voiriot","year":"2022","unstructured":"Voiriot G, Oualha M, Pierre A, Salmon-Gandonni\u00e8re C, Gaudet A, Jouan Y, et al. Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges. Ann Intensive Care. 2022;12(1):58.","journal-title":"Ann Intensive Care"},{"key":"2748_CR208","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1038\/ncomms10145","volume":"6","author":"P Rocheteau","year":"2015","unstructured":"Rocheteau P, Chatre L, Briand D, Mebarki M, Jouvion G, Bardon J, et al. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nat Commun. 2015;6:10145.","journal-title":"Nat Commun"},{"issue":"1","key":"2748_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2302\/kjm.60.1","volume":"60","author":"JM Friedman","year":"2011","unstructured":"Friedman JM. Leptin and the regulation of body weigh. Keio J Med. 2011;60(1):1\u20139.","journal-title":"Keio J Med"},{"issue":"3","key":"2748_CR210","first-page":"396","volume":"34","author":"DJ Dyck","year":"2009","unstructured":"Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity. Applied physiology, nutrition, and metabolism\u2009=\u2009physiologie appliquee. Nutr Et Metab. 2009;34(3):396\u2013402.","journal-title":"Nutr Et Metab"},{"issue":"5","key":"2748_CR211","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00125-016-3909-4","volume":"59","author":"RJ Perry","year":"2016","unstructured":"Perry RJ, Petersen KF, Shulman GI. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis. Diabetologia. 2016;59(5):933\u20137.","journal-title":"Diabetologia"},{"issue":"6649","key":"2748_CR212","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/38717","volume":"389","author":"S Kamohara","year":"1997","unstructured":"Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389(6649):374\u20137.","journal-title":"Nature"},{"issue":"12","key":"2748_CR213","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.2337\/db09-0638","volume":"58","author":"C Toda","year":"2009","unstructured":"Toda C, Shiuchi T, Lee S, Yamato-Esaki M, Fujino Y, Suzuki A, et al. Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes. 2009;58(12):2757\u201365.","journal-title":"Diabetes"},{"issue":"15","key":"2748_CR214","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/CM9.0000000000002255","volume":"136","author":"W Lu","year":"2023","unstructured":"Lu W, Feng W, Lai J, Yuan D, Xiao W, Li Y. Role of adipokines in sarcopenia. Chin Med J. 2023;136(15):1794\u2013804.","journal-title":"Chin Med J"},{"issue":"11","key":"2748_CR215","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","volume":"22","author":"DE James","year":"2021","unstructured":"James DE, St\u00f6ckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2748_CR216","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.2337\/diabetes.54.10.2939","volume":"54","author":"P Plomgaard","year":"2005","unstructured":"Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005;54(10):2939\u201345.","journal-title":"Diabetes"},{"issue":"1","key":"2748_CR217","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105\u201310.","journal-title":"J Cell Biochem"},{"key":"2748_CR218","doi-asserted-by":"publisher","first-page":"716533","DOI":"10.3389\/fendo.2021.716533","volume":"12","author":"A Armandi","year":"2021","unstructured":"Armandi A, Rosso C, Caviglia GP, Ribaldone DG, Bugianesi E. The impact of dysmetabolic sarcopenia among insulin sensitive tissues: a narrative review. Front Endocrinol. 2021;12:716533.","journal-title":"Front Endocrinol"},{"issue":"3","key":"2748_CR219","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI34275","volume":"118","author":"C Postic","year":"2008","unstructured":"Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118(3):829\u201338.","journal-title":"J Clin Invest"},{"key":"2748_CR220","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103519","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic syndrome and sarcopenia. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13103519.","journal-title":"Nutrients"},{"issue":"2","key":"2748_CR221","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/jcsm.12903","volume":"13","author":"CJ Walsh","year":"2022","unstructured":"Walsh CJ, Escudero King C, Gupta M, Plant PJ, Herridge MJ, Mathur S, et al. Microrna regulatory networks associated with abnormal muscle repair in survivors of critical illness. J Cachexia Sarcopenia Muscle. 2022;13(2):1262\u201376.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"2748_CR222","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jcsm.12266","volume":"9","author":"M Connolly","year":"2018","unstructured":"Connolly M, Paul R, Farre-Garros R, Natanek SA, Bloch S, Lee J, et al. Mir-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting. J Cachexia Sarcopenia Muscle. 2018;9(2):400\u201316.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"2748_CR223","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1164\/rccm.201701-0101OC","volume":"196","author":"RF Garros","year":"2017","unstructured":"Garros RF, Paul R, Connolly M, Lewis A, Garfield BE, Natanek SA, et al. Microrna-542 promotes mitochondrial dysfunction and SMAD activity and is elevated in intensive care unit-acquired weakness. Am J Respir Crit Care Med. 2017;196(11):1422\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2748_CR224","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jnen\/nlac024","volume":"81","author":"K Zhao","year":"2022","unstructured":"Zhao K, Li X, Zhang M, Tong F, Chen H, Wang X, et al. Microrna-181a promotes mitochondrial dysfunction and inflammatory reaction in a rat model of intensive care unit-acquired weakness by inhibiting IGFBP5 expression. J Neuropathol Exp Neurol. 2022;81(7):553\u201364.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2748_CR225","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbrc.2010.08.079","volume":"400","author":"MW Hamrick","year":"2010","unstructured":"Hamrick MW, Herberg S, Arounleut P, He HZ, Shiver A, Qi RQ, et al. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun. 2010;400(3):379\u201383.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7386","key":"2748_CR226","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10834","volume":"482","author":"TH Cheung","year":"2012","unstructured":"Cheung TH, Quach NL, Charville GW, Liu L, Park L, Edalati A, et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature. 2012;482(7386):524\u20138.","journal-title":"Nature"},{"issue":"3","key":"2748_CR227","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019712","volume":"27","author":"K Rehman","year":"2017","unstructured":"Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr. 2017;27(3):229\u201336.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"2748_CR228","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mito.2017.12.001","volume":"41","author":"CS Dela Cruz","year":"2018","unstructured":"Dela Cruz CS, Kang MJ. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion. 2018;41:37\u201344.","journal-title":"Mitochondrion"},{"issue":"4","key":"2748_CR229","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1515\/mr-2022-0017","volume":"2","author":"J Liu","year":"2022","unstructured":"Liu J, Lai F, Hou Y, Zheng R. Leptin signaling and leptin resistance. Med Rev (2021). 2022;2(4):363\u201384.","journal-title":"Med Rev (2021)"},{"key":"2748_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179469","author":"AI Mart\u00edn","year":"2021","unstructured":"Mart\u00edn AI, Priego T, Moreno-Ruperez \u00c1, Gonz\u00e1lez-Hedstr\u00f6m D, Granado M, L\u00f3pez-Calder\u00f3n A. IGF-1 and IGFBP-3 in inflammatory cachexia. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22179469.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2748_CR231","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-025-02892-8","volume":"25","author":"J Jiang","year":"2025","unstructured":"Jiang J, Chen H, Meng SS, Pan C, Xie JF, Guo FM. Early urea-to-creatinine ratio to predict rapid muscle loss in critically ill patients with sepsis: a single-center retrospective observational study. BMC Anesthesiol. 2025;25(1):26.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"2748_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05912-2","volume":"15","author":"J Kolck","year":"2025","unstructured":"Kolck J, Hosse C, Fehrenbach U, Beetz NL, Auer TA, Pille C, et al. Disease entity impacts muscle wasting in the ICU with COVID-19 patients losing muscle nearly twice as fast. Sci Rep. 2025;15(1):20176.","journal-title":"Sci Rep"},{"issue":"8","key":"2748_CR233","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.peptides.2004.06.005","volume":"25","author":"F Perfetto","year":"2004","unstructured":"Perfetto F, Tarquini R, Corn\u00e9lissen G, Mello G, Tempestini A, Gaudiano P, et al. Circadian phase difference of leptin in android versus gynoid obesity. Peptides. 2004;25(8):1297\u2013306.","journal-title":"Peptides"},{"issue":"4","key":"2748_CR234","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3892\/etm.2014.1506","volume":"7","author":"M Chen","year":"2014","unstructured":"Chen M, Wang B, Xu Y, Deng Z, Xue H, Wang L, et al. Diagnostic value of serum leptin and a promising novel diagnostic model for sepsis. Exp Ther Med. 2014;7(4):881\u20136.","journal-title":"Exp Ther Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02748-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02748-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02748-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:09:41Z","timestamp":1760616581000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02748-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2748"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02748-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}